↓ Skip to main content

A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial

Overview of attention for article published in Gastric Cancer, February 2018
Altmetric Badge

Mentioned by

twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
35 Mendeley